Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,926 | 181 | 99.5% |
| Education | $14.54 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $446.80 | 27 | $0 (2019) |
| Amgen Inc. | $418.52 | 19 | $0 (2020) |
| PFIZER INC. | $364.00 | 27 | $0 (2020) |
| Philips Electronics North America Corporation | $351.81 | 19 | $0 (2019) |
| Novo Nordisk Inc | $267.07 | 16 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $170.64 | 15 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $159.11 | 12 | $0 (2019) |
| GlaxoSmithKline, LLC. | $149.81 | 15 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $90.74 | 6 | $0 (2019) |
| ABBVIE INC. | $86.15 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $106.24 | 5 | ABBVIE INC. ($86.15) |
| 2020 | $55.33 | 3 | Amgen Inc. ($19.69) |
| 2019 | $886.85 | 53 | Amgen Inc. ($223.77) |
| 2018 | $1,172 | 78 | Philips Electronics North America Corporation ($212.69) |
| 2017 | $720.14 | 45 | Novo Nordisk Inc ($191.86) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $33.81 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Neuroscience | ||||||
| 02/26/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: STRUCTURAL HEART | ||||||
| 01/08/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/18/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/21/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/20/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/13/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Neuroscience | ||||||
| 11/06/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/30/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/23/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/16/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Neuroscience | ||||||
| 10/09/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Bone Health | ||||||
| 09/23/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/19/2019 | Vanda Pharmaceuticals Inc. | Hetlioz (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Non-24-Hour Sleep-Wake Disorder | ||||||
| 08/15/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Neuroscience | ||||||
| 07/10/2019 | BioDelivery Sciences International, Inc. | BUNAVAIL 2.1 mg 30-count box (Drug), BUNAVAIL 2.1 mg single pouch, BUNAVAIL 4.2 mg 30-count box | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Addiction Therapy | ||||||
| 07/03/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/26/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/26/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Education | In-kind items and services | $5.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 116 | 251 | $61,930 | $19,959 |
| 2021 | 5 | 261 | 500 | $107,341 | $40,236 |
| 2020 | 5 | 287 | 504 | $117,545 | $36,712 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 222 | $54,390 | $16,295 | 30.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $7,540 | $3,664 | 48.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 119 | 357 | $87,465 | $30,168 | 34.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 66 | 66 | $17,160 | $8,464 | 49.3% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 29 | 29 | $846.53 | $843.43 | 99.6% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 31 | 31 | $594.32 | $589.67 | 99.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 16 | 17 | $1,275 | $170.85 | 13.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 137 | 350 | $85,750 | $24,469 | 28.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 98 | 98 | $25,480 | $11,084 | 43.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 29 | $4,785 | $983.70 | 20.6% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 11 | 11 | $330.00 | $104.72 | 31.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 16 | 16 | $1,200 | $70.17 | 5.8% |
About Dr. Sharon Lawrence, DO
Dr. Sharon Lawrence, DO is a Internal Medicine healthcare provider based in Saint Helens, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1144218454.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sharon Lawrence, DO has received a total of $2,940 in payments from pharmaceutical and medical device companies, with $106.24 received in 2022. These payments were reported across 184 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,926).
As a Medicare-enrolled provider, Lawrence has provided services to 664 Medicare beneficiaries, totaling 1,255 services with total Medicare billing of $96,906. Data is available for 3 years (2020–2022), covering 12 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Saint Helens, OR
- Active Since 10/11/2005
- Last Updated 11/14/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1144218454
Products in Payments
- XARELTO (Drug) $281.15
- Victoza (Drug) $213.24
- Trintellix (Drug) $207.12
- INVOKANA (Drug) $165.65
- Aimovig (Biological) $153.72
- CHANTIX (Drug) $148.48
- EVENITY (Biological) $129.05
- Wellcentive Undiv (Device) $113.98
- FARXIGA (Drug) $110.64
- LYRICA (Drug) $98.79
- Respiratoriy Care Undiv (Device) $98.71
- inCourage (Device) $88.70
- Repatha (Biological) $81.35
- VIAGRA (Drug) $78.80
- JANUVIA (Drug) $75.41
- TRELEGY ELLIPTA (Drug) $64.03
- TRULICITY (Drug) $62.19
- SHINGRIX (Biological) $55.27
- Prolia (Biological) $54.40
- VRAYLAR (Drug) $52.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.